Zhaoyi Wang Selected Research

icaritin

10/2015

A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhaoyi Wang Research Topics

Disease

21	Neoplasms (Cancer) 09/2021 - 06/2006
10	Breast Neoplasms (Breast Cancer) 03/2018 - 01/2005
8	Stomach Neoplasms (Stomach Cancer) 01/2020 - 07/2010
6	Carcinogenesis 06/2018 - 01/2005
6	Lymphatic Metastasis 06/2018 - 11/2008
4	Carcinoma (Carcinomatosis) 06/2018 - 02/2011
3	Inflammation (Inflammations) 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2022
2	Myocardial Infarction 01/2022 - 01/2020
2	Wounds and Injuries (Trauma) 01/2020 - 01/2019
2	Hypersensitivity (Allergy) 01/2018 - 12/2014
2	Triple Negative Breast Neoplasms 10/2016 - 06/2014
2	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 01/2014
1	Necrosis 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Pathologic Processes 01/2022
1	Ventricular Remodeling 01/2022
1	Atherosclerosis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Osteoarthritis 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Non-alcoholic Fatty Liver Disease 08/2018
1	Neoplasm Metastasis (Metastasis) 03/2018
1	Lung Neoplasms (Lung Cancer) 07/2016
1	Asthma (Bronchial Asthma) 11/2011
1	Respiratory Hypersensitivity 11/2011
1	Wilms Tumor (Wilm's Tumor) 04/2009
1	Colorectal Neoplasms (Colorectal Cancer) 11/2008
1	Tetraploidy 12/2006
1	Glioblastoma (Glioblastoma Multiforme) 12/2006
1	Aneuploidy (Aneuploid) 12/2006

Drug/Important Bio-Agent (IBA)

11	Estrogens (Estrogen)FDA Link 01/2020 - 11/2005
8	Estrogen ReceptorsIBA 01/2020 - 11/2005
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2009
6	Estrogen Receptor alphaIBA 07/2010 - 01/2005
5	Tamoxifen FDA LinkGeneric 03/2018 - 07/2009
3	Caveolin 1IBA 02/2011 - 01/2005
3	human estrogen receptor alpha 36IBA 07/2010 - 11/2008
2	Biological ProductsIBA 01/2022 - 01/2014
2	LipidsIBA 01/2022 - 08/2018
2	Biocompatible Materials (Biomaterials)IBA 01/2020 - 01/2019
2	Endoplasmic Reticulum Chaperone BiPIBA 06/2018 - 12/2017
2	Formaldehyde (Formol)FDA Link 12/2014 - 01/2011
2	Cyclin D1IBA 12/2014 - 08/2013
2	ParaffinIBA 12/2014 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 02/2011 - 04/2009
2	Messenger RNA (mRNA)IBA 07/2010 - 11/2008
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	Elastomers (Elastomer)IBA 01/2022
1	Polyglactin 910IBA 01/2021
1	HydrogelsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 06/2018
1	Aldehyde DehydrogenaseIBA 03/2018
1	Hormones (Hormone)IBA 03/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	forsythiasideIBA 01/2018
1	AntioxidantsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Anthocyanins (Anthocyanin)IBA 10/2016
1	Antineoplastic Agents (Antineoplastics)IBA 07/2016
1	SNG1153IBA 07/2016
1	Epithelial Cell Adhesion MoleculeIBA 10/2015
1	icaritinIBA 10/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2014
1	human ERBB2 proteinIBA 06/2014
1	anthrapyrazoleIBA 01/2014
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2014
1	PolyaminesIBA 01/2014
1	pterostilbeneIBA 01/2014
1	CaspasesIBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	glucose-regulated proteinsIBA 09/2013
1	AllergensIBA 11/2011
1	MicroRNAs (MicroRNA)IBA 01/2011
1	SynucleinsIBA 08/2010
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2010
1	CytokinesIBA 12/2006
1	pleiotrophin (HARP)IBA 12/2006
1	Estrogen Receptor Modulators (Antiestrogen)IBA 06/2006

Therapy/Procedure

4	Therapeutics 01/2019 - 06/2006
3	Drug Therapy (Chemotherapy) 09/2021 - 07/2009
1	Radiotherapy 09/2021
1	Neoadjuvant Therapy 06/2014